BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36031827)

  • 1. Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
    Scalia L; Calderone D; Capodanno D
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1027-1038. PubMed ID: 36031827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
    Shah J; Liu S; Yu W
    Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
    Bhatia K; Ladd LM; Carr KH; Di Napoli M; Saver JL; McCullough LD; Hosseini Farahabadi M; Alsbrook DL; Hinduja A; Ortiz Garcia JG; Sabbagh SY; Jafarli A; Divani AA
    Curr Neurol Neurosci Rep; 2023 May; 23(5):235-262. PubMed ID: 37037980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
    Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Updates on Antiplatelet Therapy for Secondary Prevention in Acute Ischemic Stroke.
    Lee TL; Chang YM; Sung PS
    Acta Neurol Taiwan; 2023 Sep; 32(3)():138-144. PubMed ID: 37674428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
    Kim AS; Easton JD
    Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
    Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
    BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
    Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet Therapy After Noncardioembolic Stroke.
    Greving JP; Diener HC; Reitsma JB; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Algra A
    Stroke; 2019 Jul; 50(7):1812-1818. PubMed ID: 31177983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
    Hilkens NA; Algra A; Diener HC; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Greving JP
    Stroke; 2021 Oct; 52(10):3258-3265. PubMed ID: 34304604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies.
    Moustafa B; Testai FD
    Curr Neurol Neurosci Rep; 2022 Nov; 22(11):789-802. PubMed ID: 36227497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack.
    Medranda GA; Zhang C; Doros G; Yerasi C; Case BC; Weintraub WS; Waksman R
    Am J Cardiol; 2021 Aug; 153():129-134. PubMed ID: 34226040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
    Marinheiro G; Araújo B; Monteiro GA; Leite M; Mutarelli A; Almeida AM; Cavalcante-Neto JF; Rivera A; Pinheiro AC; Telles JPM
    J Neurol; 2024 Jun; 271(6):3030-3038. PubMed ID: 38580815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y12 receptor inhibitor plus aspirin versus aspirin treated within 24 hours of acute noncardioembolic ischemic stroke or TIA: Meta-analysis.
    Huang WY; Ovbiagele B; Lee M
    J Formos Med Assoc; 2022 Jun; 121(6):1053-1061. PubMed ID: 34426033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.
    Albay CEQ; Leyson FGD; Cheng FC
    BMC Neurol; 2020 Jun; 20(1):224. PubMed ID: 32493229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis.
    Pomero F; Galli E; Bellesini M; Maroni L; Squizzato A
    Eur J Intern Med; 2022 Jun; 100():46-55. PubMed ID: 35331593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Flaherty K; Havard D; Heptinstall S; James M; Krishnan K; Markus HS; Montgomery AA; Pocock SJ; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N;
    Lancet; 2018 Mar; 391(10123):850-859. PubMed ID: 29274727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.